Patent · US Revoked

Controlled release dosage forms

US8110219B2 · kind B2 · utility

0Cited by
18References
21Claims
0Family size

Assignee

Inventor

Key dates

Filing dateDec 5, 2008
Grant dateFeb 7, 2012
Priority date
Expiry dateJan 19, 2029

Classification

  • Technology area (CPC —)General

Abstract

The invention provides stable controlled release monolithic coating compositions for use in coating pharmaceutical oral dosage forms comprising a polyglycol having a melting point greater than 55° C. and an aqueous dispersion of a neutral ester copolymer lacking functional groups.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.